Su Jeong Kim Selected Research

4- methyl- 5- (2- (4- morpholinophenylamino)pyrimidin- 4- yl)thiazol- 2- amine

5/2019

An Anti-Cancer Drug Candidate CYC116 Suppresses Type I Hypersensitive Immune Responses through the Inhibition of Fyn Kinase in Mast Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su Jeong Kim Research Topics

Disease

3	Neoplasms (Cancer) 08/2021 - 01/2018
3	Melanoma (Melanoma, Malignant) 03/2018 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2020 - 07/2012
2	Proteinuria 07/2020 - 11/2019
2	Hypersensitivity (Allergy) 05/2019 - 05/2018
2	Inflammation (Inflammations) 01/2019 - 07/2017
2	Body Weight (Weight, Body) 01/2019 - 01/2018
1	Gastroenteritis 06/2021
1	Diarrhea 06/2021
1	Enterocolitis 06/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Lupus Nephritis 07/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2020
1	Splenomegaly 07/2020
1	Glomerulonephritis 07/2020
1	Nephritis 11/2019
1	Infections 10/2019
1	Anaphylaxis (Anaphylactic Shock) 05/2019
1	Atopic Dermatitis (Atopic Eczema) 05/2019
1	Allergic Rhinitis 05/2019
1	Contact Dermatitis (Eczema, Contact) 01/2019
1	Food Hypersensitivity (Food Allergy) 05/2018
1	Insulin Resistance 01/2018
1	Melanosis (Freckles) 01/2018
1	Fatty Liver 01/2018
1	Obesity 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Hyperpigmentation 01/2018
1	type 2C Congenital disorder of glycosylation 01/2018
1	Acute Promyelocytic Leukemia 07/2012
1	Leukemia 07/2012

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 11/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 05/2019 - 01/2018
2	Melanins (Melanin)IBA 03/2018 - 01/2018
2	Melanocyte-Stimulating Hormones (MSH)IBA 03/2018 - 01/2018
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2018 - 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021
1	Cholera ToxinIBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	punicalaginIBA 07/2020
1	Peptide Hydrolases (Proteases)FDA Link 07/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2020
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2019
1	Immunoglobulin G (IgG)IBA 11/2019
1	SulfurIBA 10/2019
1	AminesIBA 05/2019
1	4- methyl- 5- (2- (4- morpholinophenylamino)pyrimidin- 4- yl)thiazol- 2- amineIBA 05/2019
1	Phosphotransferases (Kinase)IBA 05/2019
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	OxazoloneIBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 05/2018
1	Proteins (Proteins, Gene)FDA Link 05/2018
1	OvalbuminIBA 05/2018
1	Aloe vera gelIBA 05/2018
1	AllergensIBA 05/2018
1	Polysaccharides (Glycans)IBA 05/2018
1	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 03/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	NAD (NADH)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	SRT1720IBA 01/2018
1	EnzymesIBA 01/2018
1	galanginIBA 01/2018
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 01/2018
1	Sirtuin 1IBA 01/2018
1	LipidsIBA 01/2018
1	ResveratrolIBA 01/2018
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2017

Therapy/Procedure

2	Hysterectomy 08/2021 - 01/2021
1	Precision Medicine 08/2021
1	Fluid Therapy (Oral Rehydration Therapy) 06/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Therapeutics 07/2020
1	Aftercare (After-Treatment) 11/2019
1	Kidney Transplantation 07/2012